ArticlePharmaceutics2024

A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro.

Sara Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.